Internal Medicine, Hematology & Oncology · St Thomas, US
NPI
1851340723
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
9150 Estate Thomas, Suite 105
St Thomas, US
Phone (340) 776-1551
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
3,709 services
Medicare patients, 2024
103
Average age 74
Drug cost, 2024
$2.5M
784 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erole M McLean was code 99214 (office e&m - established), 171 times for 81 patients. In total Erole M McLean billed 3,709 services in 51 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 171 | 81 | $82.31 | $14K |
| 36415 Venipuncture Blood Collection | Office | 155 | 69 | $8.65 | $1,341 |
| 85025 Blood Count | Office | 136 | 66 | $7.50 | $1,020 |
| 99205 Office E&M - New | Office | 12 | 12 | $157.47 | $1,890 |
By year: 2022 $64K for 8,580 services; 2023 $42K for 10,283 services; 2024 $33K for 3,709 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 155 | 69 | $8.65 | $1,341 |
| 85025 Blood Count | 136 | 66 | $7.50 | $1,020 |
Medicare prescription drug claims, 2024
In 2024, the drug Erole M McLean prescribed most often to Medicare patients was Anastrozole, with 49 prescriptions and refills. In total Erole M McLean wrote 784 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 49 | 55 | Under 11 | $911 |
| Procrit Epoetin Alfa | 36 | 36 | Under 11 | $72K |
| Eliquis Apixaban | 35 | 43 | Under 11 | $26K |
| Xgeva Denosumab | 28 | 44 | Under 11 | $89K |
| Pantoprazole Sodium Generic | 26 | 30 | Under 11 | $361 |
| Fulvestrant Generic | 24 | 24 | Under 11 | $3,109 |
| Leucovorin Calcium Generic | 24 | 27 | Under 11 | $7,494 |
| Kisqali Ribociclib Succinate | 22 | 22 | Under 11 | $392K |
| Ogivri Trastuzumab-Dkst | 20 | 20 | Under 11 | $37K |
| Revlimid Lenalidomide | 20 | 20 | Under 11 | $368K |
| Prednisone Generic | 20 | 27 | Under 11 | $230 |
| Fluorouracil Generic | 19 | 22 | Under 11 | $1,333 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 15 | 15 | Under 11 | $142K |
| Zirabev Bevacizumab-Bvzr | 15 | 15 | Under 11 | $58K |
| Hydroxyurea Generic | 15 | 31 | Under 11 | $762 |
Brand drugs: 350 claims; generic drugs: 434 claims; opioid claims: 13.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Erole M McLean were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.